10-K: HCMC Faces Going Concern, Patent Setbacks Amid Spin-Off

Healthier Choices Management Corp. reports recurring net losses and a going concern warning, despite debt restructuring and a new credit facility, following its grocery business spin-off.

Summary

• Healthier Choices Management Corp. (HCMC) completed the spin-off of its grocery and wellness business (Healthy Choice Wellness Corp. HCWC) on September 13, 2024, with HCWC becoming an independent, publicly traded company.
• HCMC's continuing operations, focused on its vaporizer business and intellectual property, reported a net loss of $7.0 million for the year ended December 31, 2025, an improvement from $8.1 million in 2024.
• Sales for continuing operations remained de minimis at $2,979 in 2025, significantly impacted by the inability to bring new products to market via distribution.
• The company settled $4.0 million of intercompany debt with HCWC on December 31, 2025, by issuing 43,889,786,222 shares of common stock, which materially improved its balance sheet.
• A $5 million revolving credit facility, established in November 2024 and extended to December 31, 2026, remains undrawn, providing immediate liquidity access.
• HCMC's patent infringement lawsuit against Philip Morris USA, Inc. was dismissed on December 31, 2024, after an appeal ruling that the underlying patent was not patentable.
• Management concluded that internal control over financial reporting was ineffective as of December 31, 2025, due to material weaknesses in IT controls.
• The company's ability to continue as a going concern is in substantial doubt due to recurring net losses and cash outflows from operations, with future success dependent on reducing consulting expenses and securing additional capital.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing with low sentiment due to persistent net losses, de minimis sales, a significant patent litigation loss, and a going concern warning, despite some positive liquidity management actions.

Positives

• Net loss from continuing operations improved to $7.0 million in 2025 from $8.1 million in 2024.
• Successfully settled $4.0 million in intercompany debt with Healthy Choice Wellness Corp. (HCWC) through equity issuance, eliminating a substantial current liability and strengthening the balance sheet.
• Secured a $5 million revolving credit facility, which remains undrawn as of December 31, 2025, providing immediate liquidity access through December 31, 2026.
• Gross profit improved from a negative $(66,305) in 2024 to a negative $(27,941) in 2025, indicating a slight reduction in the negative margin.
• Operating expenses decreased by $1.4 million, from $8.4 million in 2024 to $7.0 million in 2025, primarily due to a decrease in stock compensation.

Negatives

• HCMC reported recurring net losses and cash outflows from operations, raising substantial doubt about its ability to continue as a going concern.
• Sales for continuing operations remained de minimis at $2,979 in 2025, indicating a significant challenge in generating revenue.
• The patent infringement lawsuit against Philip Morris USA, Inc. was dismissed on December 31, 2024, after the U.S. Court of Appeals for the Federal Circuit ruled HCMC's patent was not patentable.
• Management concluded that internal control over financial reporting was ineffective as of December 31, 2025, due to material weaknesses in IT controls.
• Negative working capital of $0.3 million as of December 31, 2025.
• Net cash used in operating activities increased to $(3,881,117) in 2025 from $(3,655,629) in 2024, indicating a higher cash burn from core operations.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern due to recurring net losses and cash outflows from operations.
• Intense competition in the vaporizer and e-liquid industry from large tobacco companies (e.g., Altria Group, JT International, Imperial Tobacco, Reynolds American, Inc.) with greater resources, market penetration, and distribution channels.
• Dependence on third-party manufacturers for products; any interruption in supply or consistency could materially harm business and reputation.
• Risk of future third-party patent lawsuits alleging infringement, which could force the company to stop selling products, incur significant legal expenses, pay substantial damages, or redesign products.
• Significant regulatory developments, including FDA regulations classifying e-cigarettes as tobacco products, could impose substantial compliance costs and restrict marketing and sales.
• Potential application of federal laws like the Prevent All Cigarette Trafficking Act or the Federal Cigarette Labeling and Advertising Act to vaporizers and e-cigarettes could materially adversely affect the business.
• Cybersecurity threats, including data breaches, ransomware, and phishing attacks, pose a risk to operations, reputation, and could result in costly litigation or government enforcement action.
• The success of management's plans to address liquidity needs is dependent on reducing outside consulting expenses and securing additional capital from outside investors, with no assurance of success.

Future Outlook

Management believes its existing cash resources and available $5 million credit facility will enable it to meet obligations and capital requirements for at least the next twelve months. The success of these plans is contingent on reducing outside consulting expenses and securing additional capital from outside investors. The company is actively pursuing commercialization opportunities, including licensing negotiations, marketing and distribution with third parties, and exploring additional strategic partnerships for existing product lines.

Management Comments

• "The settlement of $4.0 million in debt through equity issuance has materially improved the Company's financial position by eliminating a significant liability while preserving cash resources."
• "The undrawn $5 million credit facility provides immediate liquidity access through December 31, 2026, with funds available for working capital needs."
• "The Company is actively pursuing commercialization opportunities, including licensing negotiation, marketing and distribution with third party, and exploration of additional strategic partnerships for existing product lines."
• "Implementation of expense reduction measures, including optimization of consulting expenditures and operational efficiencies following the spin-off of HCWC."
• "Continued evaluation of additional financing alternatives, including potential equity offerings or strategic investments, to support growth initiatives and working capital requirements."

Industry Context

StockSavvy.ai notes that HCMC operates in a highly competitive vaporizer and e-liquid industry, facing significant challenges from 'big tobacco' companies such as Altria Group, Inc., JT International, Imperial Tobacco, and Reynolds American, Inc. These larger competitors possess well-established sales and distribution channels, extensive marketing expertise, and substantial resources, positioning them to capture a larger market share. The industry is also subject to accelerating state and local regulations, in addition to broad FDA authority over tobacco products, which could disproportionately impact smaller players like HCMC due to high compliance costs and marketing restrictions.

Comparison to Industry Standards

• HCMC's de minimis sales of $2,979 in 2025 for its continuing operations are significantly lower than those of major industry players like Altria Group, Inc. (which reported net revenues of $20.4 billion in 2023) or Reynolds American, Inc. (a subsidiary of British American Tobacco, which reported global revenue of £27.28 billion in 2023). This highlights HCMC's minimal market presence and revenue generation capacity in comparison to established competitors.
• The company's recurring net losses and negative working capital stand in stark contrast to the profitability and robust financial health typically seen in larger, diversified tobacco and vaping companies, which benefit from economies of scale and diversified product portfolios.
• HCMC's dependence on third-party manufacturers and its ongoing challenges in bringing new products to market via distribution channels indicate a lack of integrated supply chain and market access capabilities that are standard among leading industry participants.

Legal Proceedings

• HCMC's patent infringement lawsuit against Philip Morris USA, Inc. and Philip Morris Products S.A. was dismissed on December 31, 2024, following a Federal Circuit ruling that the patent was not patentable.
• An ongoing patent infringement lawsuit was filed against R.J. Reynolds Vapor Company (RJR) on September 26, 2023, alleging infringement by RJR's Vuse electronic cigarette.
• A battery defect lawsuit was settled with the company's insurance carrier with no economic impact to HCMC.
• A second battery defect lawsuit was settled for $1.5 million, which was fully paid as of December 31, 2025.

Related Party Transactions

• On September 13, 2024, Healthy Choice Wellness Corp. (HCWC) was spun off from HCMC, becoming an independent entity.
• HCMC provides certain administrative and executive management services to HCWC on a transitional basis for up to one year post-spin-off, with HCWC reimbursing HCMC for shared costs.
• On December 31, 2025, HCMC settled a $4.0 million related party payable to HCWC by issuing 43,889,786,222 shares of HCMC common stock at a contractual price of $0.00009 per share.
• Following the debt settlement, HCWC owns approximately 8% of HCMC's outstanding common stock and can exercise significant influence over the company.

Stakeholder Impact

• Shareholders: The spin-off of HCWC resulted in HCMC stockholders receiving shares in the new entity. The significant dilution from the debt-for-equity swap and the ongoing net losses could negatively impact existing HCMC shareholders.
• Employees: The company is focused on cost management and operational efficiencies, which could impact staffing levels or compensation structures. Remediation efforts for internal control weaknesses may require additional training or changes in responsibilities.
• Customers: The inability to bring new products to market via distribution channels could limit product offerings and availability for customers in the vaping market.
• Creditors: The settlement of $4.0 million in intercompany debt and the availability of a $5 million credit facility improve the company's short-term liquidity, potentially benefiting creditors.
• Regulatory Authorities: The company's ineffective internal controls over financial reporting and ongoing legal proceedings will likely keep it under scrutiny from regulatory bodies like the SEC and FDA.

Next Steps

• Actively pursue commercialization opportunities, including licensing negotiations, marketing, and distribution with third parties.
• Explore additional strategic partnerships for existing product lines.
• Implement expense reduction measures, including optimization of consulting expenditures and operational efficiencies.
• Continue evaluating additional financing alternatives, including potential equity offerings or strategic investments.
• Remediate identified material weaknesses in internal controls over financial reporting, focusing on IT controls.
• Continue patent enforcement efforts, including the ongoing lawsuit against R.J. Reynolds Vapor Company.

Key Dates

Recommendation

A seasoned investor would likely issue a 'strong sell' recommendation for HCMC based on this filing. The company faces a 'going concern' warning due to persistent net losses and cash outflows, indicating fundamental operational challenges. The core vaporizer business generates de minimis sales, and a major patent infringement lawsuit was dismissed, undermining a key intellectual property asset. While debt restructuring and a credit facility provide temporary liquidity, the underlying business performance remains extremely weak, and the success of future plans is highly uncertain and dependent on external capital. The ineffective internal controls further compound the risk profile, making the stock a high-risk, low-reward proposition.

Keywords

Vaporizer, Q-Cup, Patent Infringement, SEC Filing, 10-K, Going Concern, Intellectual Property, E-cigarettes, FDA Regulation, Liquidity, Debt Restructuring, Spin-Off, HCMC